Terkko Navigator / JAMA Psychiatry

JAMA Psychiatry

Guidance for Working With a Patient Who Elicits Fear in the Psychiatrist

Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US

Association of Early Mental Health Services After an Offense With Reoffending in Psychosis

Methadone for Opioid Use Disorder

Can Depression Be Prevented? If So, How?

Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data

Sequential Psychological and Medication Therapies for Insomnia Disorder

Association Between Duration of Untreated Psychosis and Selective Cognitive Performance

Requisite Skills and the Meaningful Measurement of Cognition

Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence

Translation of Computational Psychiatry in the Context of Addiction

Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons

Prevalence of Treatment for Depression Among US Adults, 2007-2016

Errors in Figure 3

The Perils of Screening for Unhealthy Drug Use Are a Call to Action for the Mental Health Workforce

The Development of Kraepelin’s Concept of Dementia Praecox

Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior

Risks of Mortality Following Nonfatal Intentional and Unintentional Opioid Overdoses

Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic

Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?

JAMA Psychiatry

Does Degarelix Hold Potential for the Treatment of Pedophilic Disorder?—Reply

Does Degarelix Hold Potential for the Treatment of Pedophilic Disorder?

Perspectives on Cannabis Research—Barriers and Recommendations

Notice of Retraction and Replacement

Association of Suicide Prevention Interventions With Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms

Do Brief Preventive Interventions for Patients at Suicide Risk Work?

Association of End Point Definition and Trial Duration in Clinical Trials of Schizophrenia Medications

Modified Positive and Negative Syndrome Scale—A Journey of a Thousand Miles Starts With the First Step

User-Centered Psychiatric Epidemiology

Association of Symptoms of Depression With Cardiovascular Disease and Mortality

Social Isolation and Loneliness in Older Adults

Effect of Aspirin on the Prevention of Depression in Older People

Association of OPRM1 *A118G With Opioid Use Disorder

Psychosocial Interventions and Immune System Function

Psychosocial Factors in Disease and Treatment—A Call for the Biopsychosocial Model

Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence

Effectiveness of Web-Based Intervention to Prevent Depression in Patients With Back Pain

Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.gov

Combating Mental Health Challenges During the Coronavirus Disease 2019 Pandemic

JAMA Psychiatry

Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic

Questions on an RCT of Stellate Ganglion Block for Patients With Posttraumatic Stress Disorder—Reply

Questions on an RCT of Stellate Ganglion Block for Patients With Posttraumatic Stress Disorder

Clarifications to Measures, Analyses, and Findings in Trial of Stellate Ganglion Block Treatment for Posttraumatic Stress Disorder Symptoms

Suicide Prevention Research Priorities in Health Care

A Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients

A Development Pathway Towards Precision Mental Health Care

Childhood Anxiety—If We Know So Much, Why Are We Doing So Little?